These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3406453)

  • 21. Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.
    Verbakel WF; van den Berg J; Slotman BJ; Sminia P
    Acta Oncol; 2013 Apr; 52(3):652-7. PubMed ID: 23126524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The first James Kirk memorial lecture. What next in fractionated radiotherapy?
    Fowler JF
    Br J Cancer Suppl; 1984; 6():285-300. PubMed ID: 6365141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
    King CR; DiPetrillo TA; Wazer DE
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nucleo-shuttling of the ATM protein as a basis for a novel theory of radiation response: resolution of the linear-quadratic model.
    Bodgi L; Foray N
    Int J Radiat Biol; 2016; 92(3):117-31. PubMed ID: 26907628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms.
    Sugano Y; Mizuta M; Takao S; Shirato H; Sutherland KL; Date H
    Med Phys; 2015 Nov; 42(11):6203-10. PubMed ID: 26520713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?
    Daşu A; Toma-Daşu I; Fowler JF
    Phys Med Biol; 2003 Feb; 48(3):387-97. PubMed ID: 12608614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cell kinetics of human solid tumors and biological basis for fractionated radiotherapy].
    Sasaki T; Mashiyama S
    Gan No Rinsho; 1985 Sep; 31(12):1502-11. PubMed ID: 4079038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combined effects of sublethal damage repair, cellular repopulation and redistribution in the mitotic cycle. I. Survival probabilities after exposure to radiation.
    Zaider M; Wuu CS; Minerbo GN
    Radiat Res; 1996 Apr; 145(4):457-66. PubMed ID: 8600506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships.
    Thames HD; Withers HR; Peters LJ; Fletcher GH
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):219-26. PubMed ID: 7085377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy.
    Stavreva NA; Warkentin B; Stavrev PV; Fallone BG
    Med Phys; 2005 Mar; 32(3):720-5. PubMed ID: 15839343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiobiological dependences of normal tissue reactions in radiation therapy for tumors].
    Akleeva AV
    Radiats Biol Radioecol; 2014; 54(3):241-55. PubMed ID: 25764828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S; Belka C; Lauber K
    Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy dose-fractionation schedules. Hyperfractionation and accelerated treatment regimens.
    Freeman CR; Lehnert S
    Neurol Clin; 1991 May; 9(2):351-62. PubMed ID: 1944104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.
    Haas-Kogan DA; Kogan SS; Yount G; Hsu J; Haas M; Deen DF; Israel MA
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):399-403. PubMed ID: 10030268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day.
    Dale RG
    Br J Radiol; 1986 Sep; 59(705):919-27. PubMed ID: 3756389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect.
    Suwinski R; Taylor JM; Withers HR
    Radiother Oncol; 1999 Jan; 50(1):57-66. PubMed ID: 10225558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating cancer stem cells in radiation therapy treatment response modeling and the implication in glioblastoma multiforme treatment resistance.
    Yu VY; Nguyen D; Pajonk F; Kupelian P; Kaprealian T; Selch M; Low DA; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):866-75. PubMed ID: 25752402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
    Paganetti H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of stochastic fluctuation in radiation dose-rate on cell survival following fractionated radiation therapy.
    Paul S; Roy PK
    Phys Med Biol; 2012 Mar; 57(6):1561-73. PubMed ID: 22391148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.